Table 1.

Estimates of prevalence of newly diagnosed diabetes, known diabetes and IFG among Iranian adults 25–64 years old

	Impaired Fasting Glucoseab		Known DM		New DMa		New and Known DMa
	National estimatec	Prevalence (95% CI)	National estimatec	Prevalence (95% CI)	National estimatec	Prevalence (95% CI)	National estimatec	Prevalence (95% CI)
Age
25–34 (n = 843)	0.6	5.1 (3.4–7.6)	0.1	0.7 (0.3–1.5)	0.3	2.5 (1.4–4.4)	0.4	3.2 (2.0–5.0)
35–44 (n = 902)	0.9	10.0 (7.6–13.0)	0.4	4.9 (3.3–7.3)	0.4	4.3 (3.2–5.8)	0.8	9.2 (7.0–12.1)
45–54 (n = 869)	0.9	13.6 (11.5–16.1)	0.5	8.4 (6.7–10.4)	0.4	5.6 (3.5–8.7)	0.9	14.0 (11.2–17.3)
55–64 (n = 783)	0.5	14.6 (11.9–17.9)	0.4	12.1 (8.2–17.4)	0.2	6.7 (4.9–9.1)	0.6	18.8 (14.7–23.6)
Sex
Males (n = 1645)	1.5	9.3 (7.7–11.3)	0.7	4.4 (3.1–6.1)	0.6	4.0 (3.1–5.2)	1.3	8.4 (6.6–10.5)
Females (n = 1752)	1.4	9.0 (7.2–11.3)	0.8	4.9 (3.8–6.2)	0.7	4.2 (2.9–6.0)	1.4	9.1 (7.4–11.2)
Residential area
Urban (n = 2175)	2.1	9.8 (8.3–11.4)	1.1	4.9 (3.9–6.2)	1.0	4.3 (3.4–5.4)	2.1	9.2 (7.8–10.9)
Rural (n = 1222)	0.7	7.8 (5.4–11.1)	0.3	3.9 (2.4–6.1)	0.3	3.7 (2.1–6.3)	0.7	7.5 (5.2–10.9)
Total national estimate (n = 3397)	2.9	9.2 (7.9–10.7)	1.5	4.6 (3.8–5.7)	1.3	4.1 (3.3–5.1)	2.7	8.7 (7.4–10.2)

DM: Diabetes mellitus, CI: confidence interval

^a In subjects with valid fasting plasma glucose measurements

^b In non-diabetic subjects

^c Rounded to the nearest million

Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006